“…Besides the general population, a high percentage of intravenous drug users (IVD) from urban areas of Brazil, mostly HIV-1-infected, harbor HTLV-1/2 (Barbosa de Carvalho et al, 1996;Casseb et al, 1997a;Caterino-de-Araujo et al, 1998;de Araujo et al, 1994;Etzel et al, 2001;Gabbai et al, 1993;Moreira et al, 1993;Morimoto et al, 2005;Vallinoto et al, 1998). Several diseases, including adult T-cell leukemia (ATL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), other neurological syndromes, pneumonia, arthritis, bronchitis, and dermatological and urinary diseases, are associated with HTLV-1 and/or HTLV-2 infection in Brazil Macedo et al, 2004;Montanheiro et al, 2005;Pombo de Oliveira et al, 1995;Posada-Vergara et al, 2006). Accurate diagnosis of these viruses is therefore important to ensure prompt and appropriate care of infected patients.…”